Prescriber Bag reviewed

Furosemide, Covid-19 antiviral tablets cited in PBAC recommendations on items to be added to or removed from the bag All currently listed Prescriber Bag benefits remain suitable, except Covid-19 antiviral medicines and furosemide tablets, according to a new review by the Pharmaceutical Benefits Advisory Committee (PBAC). In newly published outcomes from its September meeting, the